Rainbow Childrens Medicare (RAINBOW) had a P/E of 43.2× on 6 Nov 2026, below the industry P/E of 47.7×, and the shares are 23% below their 52-week high. Its ROCE of 17% is the second-highest among the 7 largest Medical Care Facilities peers, and sales and net profit grew 13% and 9.7% a year over 3 years. Its dividend yield is 0.3%, and debt is 0.56× equity. It is a small-cap company with a market cap of ₹12,589 Cr, ranked 9th of 40 Medical Care Facilities companies by market cap; the shares fell 9.2% over the past year.
- ₹1,270.00
- ₹1,270.00
- ₹1,233.20
- ₹1,262.00
- 1.2 L
Health check
- ReturnsBehind
−9.2% over a year, better than 2 of 7 peers.
- Price tagIn line
P/E 43.2 vs industry 47.7.
- GrowthSlow
Sales +13.1%, profit +9.7% a year over 3 years.
- ProfitabilityAverage
ROCE 16.8% vs peer median 11.9%.
- Balance sheetFair
Debt 0.56× equity, interest covered 5.6×, Piotroski 5 of 9.
- Red flagsNone found
No warning signs in the headline numbers.
Small cap
Market sensitivity
Key metrics
- Market cap
- ₹12,589 Cr
- Small cap
- P/E
- 43.2
- Industry 47.7
- Price to book
- 7.36
- Peers 8.06
- Dividend yield
- 0.28%
- ROE
- 18.3%
- Peers 12.8%
- ROCE
- 16.8%
- Peers 11.9%
- Debt to equity
- 0.56
- Debt ₹968 Cr
- EPS (TTM)
- ₹28.80
- Face value ₹10
- OPM (TTM)
- 31.0%
- Net margin 15.2%
- Sales growth
- +23.2%
- Latest quarter vs a year ago
- Profit growth
- +9.1%
- Latest quarter vs a year ago
- Price to sales
- 6.55
- EV/EBITDA 24.5
Strengths and risks
Strengths
- Return on equity of 18.3%.
- Quarterly sales up 23.2% on a year ago.
- Positive operating cash flow in each of the last 4 years.
About Rainbow Childrens Medicare
Rainbow Children's Medicare Limited operates a multi-specialty pediatric, obstetrics, and gynecology hospital chain in India. The company offers medical and healthcare services to children and women. It also provides pediatric services under brand Rainbow Children's Hospital which include newborn and pediatric intensive care; pediatric multi-specialty services; and pediatric quaternary care, such as multi-organ transplantation. In addition, the company…
- Headquarters
- Hyderabad
- Employees
- 4,724
- Sector
- Healthcare
- ISIN
- INE961O01016
- Website
- rainbowhospitals.in
Price range
- Avg volume (3M)
- 1.3 L
- 1-year return
- minus 9.2%
- From 52-week high
- minus 22.7%
Analyst consensus
Peers · Medical Care Facilities
| Company | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| APOLLOHOSPApollo Hospitals Enterprise | 8,446.00 | plus 0.90% | 1,21,441 | 54.0 | 11.45 | 19.2% | 22.5% | 15.4% | 14.8% | 33.3% | 0.24% | plus 7.2% |
| MAXHEALTHMax Healthcare Institute | 934.00 | plus 0.21% | 90,909 | 66.1 | 8.03 | 12.6% | 12.8% | 26.8% | 22.4% | 9.3% | 0.21% | minus 18.1% |
| MANIPALHOSManipal Health Enterprises | 646.70 | minus 1.61% | 85,065 | 133.6 | 9.05 | 9.8% | 9.2% | 17.8% | – | – | 0.00% | minus 3.0% |
| ASTERDMAster DM Quality Care | 713.15 | minus 0.89% | 62,092 | 90.7 | 8.06 | 9.4% | 9.7% | 17.4% | 15.7% | −3.0% | 0.42% | plus 4.5% |
| FORTISFortis Healthcare | 766.90 | minus 6.45% | 57,898 | 55.7 | 5.52 | 11.9% | 10.4% | 22.2% | 13.3% | 20.9% | 0.13% | minus 19.6% |
| NHNarayana Hrudayalaya | 1,903.00 | minus 0.65% | 38,650 | 44.7 | 7.73 | 11.4% | 19.1% | 18.5% | 20.5% | 9.9% | 0.24% | plus 4.7% |
| MEDANTAGlobal Health | 1,387.60 | minus 0.15% | 37,264 | 60.4 | 8.63 | 15.0% | 15.2% | 22.1% | 17.2% | 19.5% | 0.04% | plus 11.2% |
| RAINBOWRainbow Childrens Medicare | 1,244.40 | minus 1.39% | 12,589 | 43.2 | 7.36 | 16.8% | 18.3% | 31.0% | 13.1% | 9.7% | 0.28% | minus 9.2% |
| Median of 7 peers | – | −0.65% | 62,092 | 60.4 | 8.06 | 11.9% | 12.8% | 18.5% | 16.5% | 14.7% | 0.21% | 4.5% |
Quarterly results
| ₹ Cr | Sep 25 | Dec 25 | Mar 26 | Jun 26 | Sep 26 |
|---|---|---|---|---|---|
| 445 | 445 | 460 | 470 | 548 | |
| 296 | 298 | 315 | 335 | 378 | |
| 149 | 147 | 145 | 135 | 170 | |
| 33.5% | 33.0% | 31.5% | 28.6% | 31.0% | |
| 8.2 | 10.5 | 5.1 | 12.7 | 8.1 | |
| 18.8 | 20.2 | 20.5 | 21.2 | 22 | |
| 35.8 | 39.6 | 40.9 | 42.2 | 44.6 | |
| – | – | −1.5 | – | – | |
| 102 | 97.7 | 86.8 | 84 | 112 | |
| 26.1% | 24.4% | 9.9% | 25.5% | 24.8% | |
| 75.3 | 72.5 | 77 | 60.6 | 82.1 | |
| 7.41 | 7.14 | 7.59 | 5.97 | 8.10 |
Profit & loss
- Sales CAGR 3Y
- +13.1%
- Profit CAGR 3Y
- +9.7%
- EPS CAGR 3Y
- +9.5%
- ROE
- 18.3%
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| 1,161 | 1,286 | 1,495 | 1,678 | |
| – | +10.8% | +16.3% | +12.2% | |
| 756 | 850 | 1,001 | 1,129 | |
| 405 | 436 | 494 | 548 | |
| 34.9% | 33.9% | 33.1% | 32.7% | |
| 23 | 17.2 | 10.6 | 7.9 | |
| 54.6 | 59.1 | 72.5 | 77.6 | |
| 90.3 | 112 | 138 | 151 | |
| −1.2 | 13.1 | 35.9 | 30 | |
| 282 | 295 | 330 | 358 | |
| 24.6% | 26.0% | 26.0% | 21.4% | |
| 211 | 217 | 243 | 278 | |
| – | +2.9% | +12.2% | +14.3% | |
| 20.89 | 21.38 | 23.84 | 27.41 |
Forecast
Balance sheet
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| 102 | 102 | 102 | 102 | |
| 958 | 1,157 | 1,367 | 1,547 | |
| 570 | 765 | 764 | 891 | |
| 140 | 146 | 145 | 236 | |
| 1,771 | 2,170 | 2,377 | 2,775 | |
| 976 | 1,433 | 1,439 | 1,673 | |
| 48.1 | 184 | 51.1 | 112 | |
| 208 | 3.1 | 2 | 104 | |
| 381 | 502 | 694 | 487 | |
| 158 | 48.5 | 191 | 398 | |
| 1,771 | 2,170 | 2,377 | 2,775 |
Cash flow
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| 329 | 321 | 396 | 420 | |
| −465 | −226 | −268 | −259 | |
| 143 | −102 | −118 | −147 | |
| 7 | −6.8 | 10.1 | 13.6 | |
| −141 | −354 | −146 | −216 | |
| 187 | −32.2 | 250 | 203 | |
| −20.3 | −30.8 | −30.5 | −30.5 |
Shareholding pattern
- Promoters49.83%
- Public49.77%
- Employee trusts0.40%
| Quarter | Split | Promoters | Public | Promoter change |
|---|---|---|---|---|
| 30 Sep 2026 | 49.83% | 49.77% | minus 0.01 | |
| 30 Jun 2026 | 49.84% | 49.98% | 0.00 | |
| 31 Mar 2026 | 49.84% | 50.04% | 0.00 | |
| 31 Dec 2025 | 49.84% | 50.12% | minus 0.01 | |
| 30 Sep 2025 | 49.85% | 50.15% | – |
Major shareholders
Filings & events
News
No recent news coverage found.